ALZAMER® DepotTM Bioerodible Polymer Technology
2002
With the advent of therapeutic biomolecules produced by the biotechnology industry, the need for convenient sustained delivery of proteins and other biomolecules has greatly increased. The Alzamer Depot technology was designed to
offer sustained delivery of therapeutic agents, including proteins, peptides, other
biomolecules, and small-molecular-weight compounds, for up to a month with
minimal initial drug burst, and bioerosion of the dosage form.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
48
References
19
Citations
NaN
KQI